Covid-19 roundup: Pieris to investigate treatment of long Covid with Bavarian grant money; A rollercoaster year ends in FDA OK for repurposed Covid drug

Another respiratory drug is being developed for the treatment of Covid-19.

Pieris Pharmaceuticals announced Friday that the inhaled CTGF inhibitor PRS …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Pieris to in­ves­ti­gate treat­ment of long Covid with Bavar­i­an grant mon­ey; A roller­coast­er year ends in FDA OK for re­pur­posed Covid drug